Inhibitory effect of O-propargyllawsone in A549 lung adenocarcinoma cells.
Dos Santos EWP, de Sousa RC, de Franca MNF, Santos JF, Ottoni FM, Isidório RG, de Lucca Junior W, Alves RJ, Scher R, Corrêa CB.
Dos Santos EWP, et al.
BMC Complement Med Ther. 2023 Sep 20;23(1):333. doi: 10.1186/s12906-023-04156-9.
BMC Complement Med Ther. 2023.
PMID: 37730601
Free PMC article.